Novel cholix toxin variants, adp-ribosylating toxins in vibrio cholerae non-o1/non-o139 strains, and their pathogenicity

Infection and Immunity

Volumn 81, Issue 2, 2013, Pages 531-541

  Awasthi, Sharda Prasad ^a   Asakura, Masahiro ^a   Chowdhury, Nityananda ^a,e   Neogi, Sucharit Basu ^a,f   Hinenoya, Atsushi ^a   Golbar, Hossain M ^b   Yamate, Jyoji ^b   Arakawa, Eiji ^c   Tada, Toshiji ^a   Ramamurthy, T ^d   Yamasaki, Shinji ^a  

^a Osaka Prefecture University   (Japan)

^b Veterinary Pathology   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^e UNIVERSITY OF DELAWARE   (United States)

^f INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; CHOLIX TOXIN; SIGNAL PEPTIDE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; CYTOTOXICITY; ENZYME ACTIVE SITE; GENE SEQUENCE; GENETIC VARIABILITY; INDEL MUTATION; MORTALITY; NECROSIS; NONHUMAN; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHYLOGENETIC TREE; PHYLOGENY; PRIORITY JOURNAL; RABBIT; RECEPTOR BINDING; VIBRIO CHOLERAE;

ADP RIBOSE TRANSFERASES; ADP-RIBOSYLATION FACTORS; AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CHOLERA TOXIN; GENETIC VARIATION; HEPATOCYTES; MALE; MICE; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; RABBITS; VIBRIO CHOLERAE; VIBRIO CHOLERAE NON-O1; VIBRIO CHOLERAE O139; VIRULENCE FACTORS;

EID: 84873049877     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00982-12     Document Type: Article

References (50)

1. WHO.July 2012. Cholera. Media centre fact sheet no. 107.WHO, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs107/en/.
2. Sharma C, Thungapathra M, Ghosh A, Mukhopadhyay AK, Basu A, Mitra R, Basu I, Bhattacharya SK, Shimada T, Ramamurthy T, Takeda T, Yamasaki S, Takeda Y, Nair GB. 1998. Molecular analysis of Vibrio cholerae non-O1, non-O139 associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India. J. Clin. Microbiol. 36:756-763.
3. Faruque SM, Chowdhury N, Kamruzzaman M, Dziejman M, Rahman MH, Sack DA, Nair GB, Mekalanos JJ. 2004. Genetic diversity and virulence potential of environmental Vibrio cholerae population in a cholera- endemic area. Proc. Natl. Acad. Sci. U. S. A. 101:2123-2128.
4. Chatterjee S, Ghosh K, Raychoudhuri A, Chowdhury G, Bhattacharya MK, Mukhopadhyay AK, Ramamurthy T, Bhattacharya SK, Klose KE, Nandy RK. 2009. Incidence, virulence factors, and clonality among clinical strains of non-O1, non-O139 Vibrio cholerae isolates from hospitalized diarrheal patients in Kolkata, India. J. Clin. Microbiol. 47:1087-1095.
5. Dziejman M, Serruto D, Tam VC, Sturtevant D, Diraphat P, Faruque SM, Rahman MH, Heidelberg JF, Decker J, Li L, Montgomery KT, Grills G, Kucherlapati R, Mekalanos JJ. 2005. Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system. Proc. Natl. Acad. Sci. U. S. A. 102:3465-3470.
6. Pukatzki S, Ma AT, Sturtevant D, Krastins B, Sarracino D, Nelson WC, Heidelberg JF, Mekalanos JJ. 2006. Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc. Natl. Acad. Sci. U. S. A. 103:1528-1533.
7. Sarkar B, Bhattacharya T, Ramamurthy T, Shimada T, Takeda Y, Nair GB. 2002. Preferential association of the heat-stable enterotoxin gene (stn) with environmental strains of Vibrio cholerae belonging to the O14 serogroup. Epidemiol. Infect. 129:245-251.
8. Ghosh A, Saha DR, Hoque KM, Asakura M, Yamasaki S, Koley H, Das SS, Chakrabarti MK, Pal A. 2006. Enterotoxigenicity of mature 45- kilodalton and processed 35-kilodalton forms of hemagglutinin protease purified from a cholera toxin gene-negative Vibrio cholerae non-O1, non- O139 strain. Infect. Immun. 74:2937-2946.
9. Fasano A, Baudry B, Pumplin DW, Wasserman SS, Tall BD, Ketley JM, Kaper JB. 1991. Vibrio cholerae produces a second enterotoxin which affects intestinal tight junctions. Proc. Natl. Acad. Sci. U. S. A. 88:5242-5246.
10. Fasano A, Fiorentini C, Donelli G, Uzzau S, Kaper JB, Margaretten K, Ding X, Guandalini S, Comstock L, Goldblum SE. 1995. Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. J. Clin. Invest. 96:710-720.
11. Rui H, Ritchie JM, Bronson RT, Mekalanos JJ, Zhang Y, Waldor MK. 2010. Reactogenicity of live-attenuated Vibrio cholerae vaccines is dependent on flagellins. Proc. Natl. Acad. Sci. U. S. A. 107:4359-4364.
12. Queen J, Satchell KJ. 2012. Neutrophils are essential for containment of Vibrio cholerae to the intestine during the proinflammatory phase of infection. Infect. Immun. 80:2905-2913.
13. Krueger KM, Barbieri JT. 1995. The family of bacterial ADP-ribosylating exotoxins. Clin. Microbiol. Rev. 8:34-47.
14. Jørgensen R, Purdy AE, Fieldhouse RJ, Kimber MS, Bartlett DH, Merrill AR. 2008. Cholix toxin, a novel ADP-ribosylating factor from Vibrio cholerae. J. Biol. Chem. 283:10671-10678.
15. Purdy A, Rohwer F, Edwards R, Azam F, Bartlett DH. 2005. A glimpse into the expanded genome content of Vibrio cholerae through identification of genes present in environmental strains. J. Bacteriol. 187:2992-3001.
16. Wilson BA, Collier RJ. 1992. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active site structure and enzymatic mechanism. Curr. Top. Microbiol. Immunol. 175:27-41.
17. Collier RJ. 1975. Diphtheria toxin: mode of action and structure. Bacteriol. Rev. 39:54-85.
18. Hoshino K, Yamasaki S, Mukhopadhyay AK, Chakraborty S, Basu A, Bhattacharya SK, Nair GB, Shimada T, Takeda Y. 1998. Development and evaluation of a multiplex PCR assay for rapid detection of toxigenic Vibrio cholerae O1 and O139. FEMS Immunol. Med. Microbiol. 20:201-207.
19. Shimada T, Arakawa T, Itoh K, Okitsu T, Matsushima A, Asai Y, Yamai S, Nakazato T, Nair GB, Albert MJ, Takeda Y. 1994. Extended serotyping scheme for Vibrio cholerae. Curr. Microbiol. 28:175-178.
20. Lin Z, Yamasaki S, Kurazono H, Ohmura M, Karasawa T, Inoue T, Sakamoto S, Suganami T, Takeoka T, Taniguchi Y. 1993. Cloning and sequencing of two new verotoxin 2 variant genes of Escherichia coli isolated from cases of human and bovine diarrhea. Microbiol. Immunol. 37:451-459.
21. Asakura M, Samosornsuk W, Taguchi M, Kobayashi K, Misawa N, Kusumoto M, Nishimura K, Matsuhisa A, Yamasaki S. 2007. Comparative analysis of cytolethal distending toxin (cdt) genes among Campylobacter jejuni, C. coli and C. fetus strains. Microb. Pathog. 42:174-183.
22. Yamasaki S, Nair GB, Bhatacharya SK, Yamamoto S, Kurazono H, Takeda Y. 1997. Cryptic appearance of a new clone of Vibrio cholerae serogroup O1 biotype El Tor in Calcutta, India. Microbiol. Immunol. 41:1-6.
23. Yutsudo T, Nakabayashi N, Hirayama T, Takeda Y. 1987. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb. Pathog. 3:21-30.
24. De SN, Chatterjee DN. 1953. An experimental study of the mechanisms of action of Vibrio cholerae on the intestinal mucous membrane. J. Pathol. Bacteriol. 46:559-562.
25. Yutsudo T, Honda T, Miwatani T, Takeda Y. 1986. Characterization of purified Shiga toxin from Shigella dysenteriae 1. Microbiol. Immunol. 30: 1115-1127.
26. Dalsgaard A, Serichantalergs O, Forslund A, Lin W, Mekalanos J, Mintz E, Shimada T, Wells JG. 2001. Clinical and environmental isolates of Vibrio cholerae serogroup O141 carry the CTX phage and the genes encoding the toxin-coregulated pili. J. Clin. Microbiol. 39:4086-4092.
27. Crump JA, Bopp CA, Greene KD, Kubota KA, Middendorf RL, Wells JG, Mintz ED. 2003. Toxigenic Vibrio cholerae serogroup O141-associated cholera-like diarrhea and bloodstream infection in the United States. J. Infect. Dis. 187:866-868.
28. Nakayama K. 1997. Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J. 327:625-635.
29. Ogata M, Chaudhary VK, Pastan I, FitzGerald DJ. 1990. Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37, 000-Da toxin fragment that is translocated to the cytosol. J. Biol. Chem. 265:20678-20685.
30. Lory S, Collier RJ. 1980. Expression of enzymic activity by exotoxin A from Pseudomonas aeruginosa. Infect. Immun. 28:494-501.
31. Tian S, Huajun W, Wu J. 2012. Computational prediction of furin cleavage sites by a hybrid method and understanding mechanism underlying diseases. Sci. Rep. 2:261. doi:10.1038/srep.00261.
32. Sedlock DM, Deibel RH. 1978. Detection of Salmonella enterotoxin using rabbit ileal loops. Can. J. Microbiol. 24:268-273.
33. Duncan CL, Sugiyama H, Strong DH. 1968. Rabbit ileal loop response to strains of Clostridium perfringens. J. Bacteriol. 95:1560-1566.
34. Leitch GJ, Iwert ME, Burrows W. 1966. Experimental cholera in the rabbit ligated ileal loop: toxin-induced water and ion movement. J. Infect. Dis. 116:303-312.
35. Hirakata Y, Furuya N, Tateda K, Kaku M, Yamaguchi K. 1993. In vivo production of exotoxin A and its role in endogenous Pseudomonas aeruginosa septicemia in mice. Infect. Immun. 61:2468-2473.
36. Doring G, Goldstein W, Roll A, Schiotz PO, Hoiby N, Botzenhart K. 1985. Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis. Infect. Immun. 49:557-562.
37. Sharma S, Kaur R, Yadav V, Harjai K, Joshi K. 2004. Contribution of exotoxin A of Pseudomonas aeruginosa in acute and chronic experimental renal infection. Jpn. J. Infect. Dis. 57:119-120.
38. Forristal JJ, Thompson MR, Morris RE, Saelinger CB. 1991. Mouse liver contains a Pseudomonas aeruginosa exotoxin A-binding protein. Infect. Immun. 59:2880-2884.
39. Kreitman RJ, Batra JK, Seetharam S, Chaudhary VK, FitzGerald DJ, Pastan I. 1993. Single-chain immunotoxin fusions between anti-Tac and Pseudomonas exotoxin: relative importance of the two toxin disulfide bonds. Bioconjug. Chem. 4:112-120.
40. Seetharam S, Chaudhary VK, FitzGerald D, Pastan I. 1991. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL. J. Biol. Chem. 266:17376-17381.
41. Sarnovsky R, Tendler T, Makowski M, Kiley M, Antignani A, Traini R, Zhang J, Hassan R, FitzGerald DJ. 2010. Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin. Cancer Immunol. Immunother. 59:737-746.
42. Lewis MJ, Sweet DJ, Pelham HR. 1990. The ERD2 gene determines the specificity of the luminal ER protein retention system. Cell 61:1359-1363.
43. Semenza JC, Hardwick KG, Dean N, Pelham HR. 1990. ERD2, a yeast gene required for the receptor-mediated retrieval of luminal ER proteins from the secretory pathway. Cell 61:1349-1357.
44. Vitale A, Ceriotti A, Denecke J. 1993. The role of the endoplasmic reticulum in protein synthesis, modification and intracellular transport. J. Exp. Bot. 44:1417-1444.
45. Lewis MJ, Pelham HR. 1990. A human homologue of the yeast HDEL receptor. Nature 348:162-163.
46. Wilson DW, Lewis MJ, Pelham HR. 1993. pH-dependent binding of KDEL to its receptor in vitro. J. Biol. Chem. 268:7465-7468.
47. Hessler JL, Kreitman RJ. 1997. An early step in Pseudomonas exotoxin action is removal of the terminal lysine residue, which allows binding to the KDEL receptor. Biochemistry 36:14577-14582.
48. Bartlett DH, Azam F. 2005. Microbiology: chitin, cholera, and competence. Science 310:1775-1777.
49. Meibom KL, Blokesch M, Dolganov NA, Wu CY, Schoolnik GK. 2005. Chitin induces natural competence in Vibrio cholerae. Science 310:1824-1827.
50. Udden SM, Zahid MS, Biswas K, Ahmad QS, Cravioto A, Nair GB, Mekalanos JJ, Faruque SM. 2008. Acquisition of classical CTX prophage from Vibrio cholerae O141 by El Tor strains aided by lytic phages and chitin-induced competence. Proc. Natl. Acad. Sci. U. S. A. 105:11951-11956.